Ming‐Lung Yu

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹

Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah et al. · Autophagy · 2021 · 2.6K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +9

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

Shi‐Ming Lin, Ming‐Lung Yu, Chuan–Mo Lee et al. · Journal of Hepatology · 2006 · 309 citations

Medicine, Internal Medicine, Pharmacotherapy +15

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Ming‐Lung Yu, CY Dai, Jee‐Fu Huang et al. · Gut · 2006 · 285 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

Ming‐Lung Yu, Chia‐Yen Dai, Jee‐Fu Huang et al. · Hepatology · 2008 · 278 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17